Tenax Therapeutics (TENX) Change in Account Payables (2024 - 2026)
Tenax Therapeutics (TENX) posted quarterly Change in Account Payables of $449000.0 for Q2 2026, up 135.16% year-over-year from $190933.4 in Q2 2025, and up 47.21% on a QoQ basis from $305000.0 in Q1 2026.
Tenax Therapeutics (TENX) Change in Account Payables (2024 - 2026) Analysis & Trends
Tenax Therapeutics has reported Change in Account Payables for 3 years, with the latest figure at $449000.0 in Q2 2026.
- Change in Account Payables for Q2 2026 came in at $449000.0, up 135.16% year-over-year; the trailing twelve-month figure through Jun 2026 was $6.2 million (up 2097.76% YoY), and the FY2025 annual result was $2.9 million, up 171.56% from the prior year.
- Change in Account Payables advanced to $449000.0 in Q2 2026, from $305000.0 in the prior quarter.
- Over five years, Change in Account Payables peaked at $5.0 million in Q3 2025 and troughed at -$1.3 million in Q1 2025.
- A 3-year average of $470000.0 and a median of $368500.0 in 2025 frame the typical range for Change in Account Payables.
- The largest YoY upside for Change in Account Payables was 612.85% in 2025 against a maximum downside of 477.83% in 2025.
- A 3-year view of Change in Account Payables shows it stood at $1.6 million in 2024, then sank by 72.57% to $432000.0 in 2025, then climbed by 3.94% to $449000.0 in 2026.
- Per Business Quant data, the three most recent Change in Account Payables figures were $449000.0 in Q2 2026, $305000.0 in Q1 2026, and $432000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -8.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 37.53 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Tenax Therapeutics | 78.47 Mn | 78.47 Mn | - | 449,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 449,000.00 |
| Jun 30, 2026 | 449,000.00 |
| Mar 31, 2026 | 305,000.00 |
| Mar 31, 2026 | 305,000.00 |
| Dec 31, 2025 | 432,000.00 |
| Dec 31, 2025 | 432,000.00 |
| Sep 30, 2025 | 5.05 Mn |
| Sep 30, 2025 | 5.05 Mn |
| Jun 30, 2025 | -1.28 Mn |
| Jun 30, 2025 | -1.28 Mn |
| Mar 31, 2025 | -1.32 Mn |
| Mar 31, 2025 | -1.32 Mn |
| Dec 31, 2024 | 1.58 Mn |
| Dec 31, 2024 | 1.58 Mn |
| Sep 30, 2024 | 708,000.00 |
| Sep 30, 2024 | 708,000.00 |
| Jun 30, 2024 | -221,000.00 |
| Jun 30, 2024 | -221,000.00 |
| Mar 31, 2024 | -1.00 Mn |
| Mar 31, 2024 | -1.00 Mn |